Internal Medicine, Endocrinology, Diabetes, & Metabolism · Miami, FL
NPI
1699977884
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8500 SW 92nd St Ste 201
Miami, FL, 33156
Phone (786) 703-3557
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
490 services
Medicare patients, 2024
149
Average age 72
Drug cost, 2024
$4.1M
12,008 prescriptions
Company payments, 2025
$156
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yanelis Martin was code 99214 (office e&m - established), 363 times for 133 patients. In total Yanelis Martin billed 490 services in 8 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 363 | 133 | $97.52 | $35K |
| 99204 Office E&M - New | Office | 34 | 34 | $118.06 | $4,014 |
| 76536 Ultrasound - Nonspecific | Office | 32 | 30 | $80.37 | $2,572 |
| 99215 Office E&M - Established | Office | 23 | 16 | $143.55 | $3,302 |
| 99213 Office E&M - Established | Office | 18 | 18 | $72.23 | $1,300 |
| 99205 Office E&M - New | Office | 12 | 12 | $176.81 | $2,122 |
By year: 2022 $38K for 362 services; 2023 $54K for 548 services; 2024 $49K for 490 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yanelis Martin prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,156 prescriptions and refills. In total Yanelis Martin wrote 12,008 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,156 | 2,851 | 367 | $9,983 |
| Ozempic Semaglutide | 908 | 1,107 | 179 | $1.0M |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 810 | 1,136 | 283 | $4,220 |
| Metformin Hcl Generic | 709 | 1,640 | 272 | $2,036 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 702 | 1,258 | 204 | $98K |
| Synthroid Levothyroxine Sodium | 648 | 1,177 | 152 | $53K |
| Glipizide Generic | 554 | 1,384 | 194 | $3,757 |
| Pioglitazone Hcl Generic | 425 | 1,061 | 158 | $2,947 |
| Trulicity Dulaglutide | 376 | 405 | 67 | $388K |
| Mounjaro Tirzepatide | 375 | 455 | 64 | $483K |
| Jardiance Empagliflozin | 370 | 592 | 92 | $349K |
| Metformin Hcl Er Metformin Hcl | 341 | 830 | 121 | $2,125 |
| Novolog Flexpen Insulin Aspart | 333 | 408 | 80 | $64K |
| Tradjenta Linagliptin | 295 | 421 | 68 | $216K |
| Farxiga Dapagliflozin Propanediol | 294 | 427 | 65 | $237K |
Brand drugs: 6,410 claims; generic drugs: 4,879 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yanelis Martin $156 ($156 in general payments such as food, travel and fees) from 3 companies. The largest payer was Novo Nordisk Inc with $116.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.